News/ News/ Oncology J&J hits back over asbestos in talc claims Phil Taylor asbestos, J&J, litigation, talc 0 Comment Shares in Johnson & Johnson slid around 10% on Friday after a Reuters article claimed the company had Share X J&J hits back over asbestos in talc claims https://pharmaphorum.com/news/jj-hits-back-over-asbestos-in-talc-claims/
